The effects of gintonin against Parkinson’s disease are mediated via Lpar1 (Choi et al., 2018), and the Lpar1/Edg2 was downregulated in Parkinson’s disease rat model (Yang et al., 2015). The gene discussed is LPAR1; the disease is Parkinson disease.